MM
Mancini Marianna
Chief Operating Officer
OtherF
Insider track record
ExecutiveAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Mancini Marianna, Chief Operating Officer. Director active across 1 company, notably Viking Therapeutics, Inc.. Cumulatively, 15 filings have been published. Activity tracked since 28 September 2021. The latest transaction was filed on 2 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
7,667 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093791:0
44,533 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002486:0
10,000 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088537:0
17,999 shares@ US$4.6816.1% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-005486:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005118:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004232:0
28,334 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000930:0
12,500 shares@ US$13.0730.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024723:0
23,100 shares@ US$8.5237.1% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-022396:0
15,000 shares@ US$2.156.1% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-021743:0
1,079 shares@ US$8.951.8% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-003606:0
23,500 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001342:0
827 shares@ US$4.240.0001% mcap7.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-008999:0
3,919 shares@ US$4.880.0005% mcap42.3% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-001987:0
6,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058249:0
About Mancini Marianna
Marianna Mancini is the Chief Operating Officer of Viking Therapeutics, Inc. She is responsible for overseeing the company's daily operations, ensuring efficiency and profitability. Her role is crucial in supporting Viking's growth strategy.